Neurovascular medical devices for aneurysm, stroke, and arterial disease treatment
Terumo Neuro manufactures minimally invasive devices for neurovascular conditions, with a 1,000+ person operation spanning R&D, manufacturing, and direct sales across 70+ countries. The hiring mix is heavily skewed toward manufacturing and engineering roles, while active projects cluster around product launches, territory expansion, and sterilization validation—reflecting a company scaling production capacity and market reach rather than undergoing platform transformation. The tech stack is dominated by enterprise legacy (SAP, Hyperion Essbase, Windows, Access) and CAD tools (SolidWorks, Pro/ENGINEER, AutoCAD), with no active migration signals.
Terumo Neuro, originally founded as MicroVention in 1997 and acquired by Japan-based Terumo Corporation in 2006, develops and manufactures over 30 neurovascular interventional devices targeting cerebral aneurysms, ischemic stroke, carotid artery disease, and arterial malformations. The company operates manufacturing facilities in Aliso Viejo, California and San José, Costa Rica, and distributes through both direct sales teams and strategic partners across more than 70 countries. With 1,001–5,000 employees and hiring activity across the United States, Costa Rica, France, Argentina, South Korea, Canada, and Italy, Terumo Neuro maintains a physician-facing sales organization alongside product development and regulatory compliance infrastructure.
SAP (ERP), SolidWorks and Pro/ENGINEER (CAD), Hyperion Essbase (analytics), Power BI (reporting), Altium Designer and Allegro (circuit design), Windchill (product lifecycle), Windows/Microsoft 365 (productivity), and Minitab (statistical analysis).
Terumo Neuro is headquartered in Aliso Viejo, California, with a second major manufacturing facility in San José, Costa Rica.
Other companies in the same industry, closest in size